Thursday, July 11, 2013 4:56:45 PM
I see what you are saying. We should all be on here to share ideas how to trade the best to make the most profit together. All of the drama can be saved for other boards as far as I'm concerned. The one point that I see differently than you is that they are forward looking statements. They released results from trials that just finished. That isn't forward looking BUT can be used as a forward-looking statement for investing purposes and it should be. If trial after trial is proving that something is working, chances are it will work next time around as well. I am not sure how other people invest but I look at results when it comes to biotech companies because that is the only thing that matters. If their science is proving to be valid then I find it worthy to invest in for the future. That decision is based on these type of PR's. I want to know results and plans.
I DO agree with you that there will be a chance to enter in lower once they excitement settles some. Hard thing with this company is the timing. They are at a point where there is many good things about to take place so it becomes riskier. I suggest finding a decent entry and going long. Then take some extra to play the swings if you want but keep a nice chunk long the entire time.
No hostilities my friend. I wish is ALL on this board the best health and prosperity. This board had impressed me with the class it has upheld in the past. Let us all keep it that way and help each other, even when we disagree!
I DO agree with you that there will be a chance to enter in lower once they excitement settles some. Hard thing with this company is the timing. They are at a point where there is many good things about to take place so it becomes riskier. I suggest finding a decent entry and going long. Then take some extra to play the swings if you want but keep a nice chunk long the entire time.
No hostilities my friend. I wish is ALL on this board the best health and prosperity. This board had impressed me with the class it has upheld in the past. Let us all keep it that way and help each other, even when we disagree!
Recent INO News
- Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China • PR Newswire (US) • 05/21/2026 08:05:00 PM
- INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights • PR Newswire (US) • 05/13/2026 08:05:00 PM
- INOVIO to Participate in Upcoming Scientific Conferences • PR Newswire (US) • 05/08/2026 12:05:00 PM
- INOVIO to Report First Quarter Financial Results on May 13, 2026 • PR Newswire (US) • 05/01/2026 08:05:00 PM
- INO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Inovio Pharmaceuticals, Inc. Securities Lawsuit -- The Gross Law Firm • PR Newswire (US) • 04/07/2026 01:00:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 04/06/2026 07:46:00 AM
- INOVIO Announces Pricing of $17.5 Million Public Offering • PR Newswire (US) • 04/02/2026 12:55:00 PM
- INOVIO Announces Proposed Public Offering • PR Newswire (US) • 04/02/2026 12:05:00 AM
- INOVIO to Participate in Upcoming Scientific Conference • PR Newswire (US) • 04/01/2026 02:29:00 PM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/31/2026 01:00:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 03/30/2026 07:47:00 AM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/24/2026 01:00:00 PM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/17/2026 01:00:00 PM
- INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • PR Newswire (US) • 03/12/2026 08:05:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO • PR Newswire (US) • 03/10/2026 01:00:00 PM
- INOVIO to Participate in Upcoming Scientific Conferences • PR Newswire (US) • 03/09/2026 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:55:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:54:42 PM
- INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 • PR Newswire (US) • 03/05/2026 09:05:00 PM
- INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM) • PR Newswire (US) • 03/04/2026 01:05:00 PM
- Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO • PR Newswire (US) • 03/03/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:49:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:48:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:47:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:47:13 PM
